Healthcare

• CSL remains one of Australia's largest biotechnology companies with a diversified portfolio of plasma therapies, vaccines and specialty medicines.

• Syntara shares rose 4.35% to AUD 0.024 during the morning session on 6 July 2026 after the company released preliminary Phase 2 data for SNT-4728.

• Cynata Therapeutics shares rose 15.38% on 6 July 2026 following the company's strategic restructuring announcement.

Cynata is uniquely identified as having a Strong Buy analyst rating, making it stand out among the companies in this dataset. The following covers the company's background and key investor considerations.

A 23 percent fall is a significant single-session decline that warrants investigation of any accompanying news. The following covers the company's background and key investor considerations.

PYC has captured attention after featuring among the session's decliners on the ASX. A decline of about 3.41% in a single session is enough to place PYC on screens that track the day's biggest movers, particularly for a stock of its size. Such pullbacks …

Medical Developments International has moved onto investors' radars primarily because of its recent share-price action. A decline of about 5.68% in a single session is enough to place MVP on screens that track the day's biggest movers, particularly for a stock of its size. …